Journal
RADIOTHERAPY AND ONCOLOGY
Volume 139, Issue -, Pages 83-86Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2019.07.018
Keywords
Prostate cancer; Phase I/II trial; SBRT; Toxicity; Monotherapy
Funding
- Fondation pour les recherches medicales et biologiques sur le cancer (Clinique de Carouge SA, Carouge GE, Forni Foundation, Switzerland)
Ask authors/readers for more resources
The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking. (C) 2019 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
